Pneumococcal 15-Valent Conjugate Vaccine Gets Priority Review for Pediatric Use By Brian Park, PharmD Publish Date December 1, 2021
Negative Allosteric Modulator Gets Fast Track Status for Social Anxiety Disorder By Brian Park, PharmD Publish Date December 1, 2021
Cyclophilin Inhibitor Fast Tracked for Nonalcoholic Steatohepatitis By Brian Park, PharmD Publish Date November 30, 2021
FDA Rejects Pedmark NDA Again Citing Manufacturing Deficiencies By Brian Park, PharmD Publish Date November 30, 2021
Olaparib Gets Priority Review for BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer By Brian Park, PharmD Publish Date November 30, 2021
Additional Data Support Efficacy of Molnupiravir for Mild to Moderate COVID-19 By Brian Park, PharmD Publish Date November 29, 2021
Deucravacitinib Under Review for Moderate to Severe Plaque Psoriasis By Brian Park, PharmD Publish Date November 29, 2021
Bimekizumab Significantly Improves Joint, Skin Symptoms in Psoriatic Arthritis By Brian Park, PharmD Publish Date November 23, 2021
Linzagolix Under Review for Treatment of Uterine Fibroids By Brian Park, PharmD Publish Date November 22, 2021
One-Time Gene Therapy Gets Priority Review for Beta-Thalassemia By Brian Park, PharmD Publish Date November 22, 2021
Bulevirtide BLA Submitted for Chronic Hepatitis Delta Virus Infection By Brian Park, PharmD Publish Date November 19, 2021
NDA Submitted for Aprepitant 30-Second IV Injection for Postoperative Nausea, Vomiting By Brian Park, PharmD Publish Date November 19, 2021
Long-Acting Antibody Combo Reduced Risk of Symptomatic COVID-19 in Phase 3 Trials By Brian Park, PharmD Publish Date November 18, 2021
Oral WEE1 Inhibitor Gets Fast Track Status for Uterine Serous Carcinoma By Brian Park, PharmD Publish Date November 18, 2021
Potassium Binder Fast Tracked for Reducing CV Outcomes in Chronic Hemodialysis By Brian Park, PharmD Publish Date November 17, 2021
Pfizer Seeks EUA for Paxlovid, a Novel Oral Antiviral for COVID-19 By Brian Park, PharmD Publish Date November 17, 2021
Setmelanotide Gets Priority Review for Bardet-Biedl Syndrome and Alström Syndrome By Brian Park, PharmD Publish Date November 16, 2021
Empagliflozin Gets Priority Review for Heart Failure Independent of LVEF By Brian Park, PharmD Publish Date November 11, 2021
Rivoceranib Designated Orphan Drug for Hepatocellular Carcinoma By Brian Park, PharmD Publish Date November 11, 2021
Intranasal Nalmefene Fast Tracked for Opioid Overdose Treatment By Brian Park, PharmD Publish Date November 10, 2021
